The medication doesn't work overnight
There is currently no government-mandated fixed price for Ozempic in the private healthcare sector in Malaysia
#EliLilly #ObesityCare #Foundayo #HealthcareInnovation #FDAApproval #WeightLossJourney #PharmaNews To view or add a comment, sign in Eli Lilly secures FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 pill for chronic weight management in adults with obesity or overweight with weight-related conditions
Appearance: loose powder, from light to dark brown colour with a characteristic odor, insoluble in water
The investigators also noted that the association between GLP-1 RA use and improved outcomes was strongest among patients with chronic limb-threatening ischemia and those with obesity (body mass index 30 kg/m), reported the AHA press release
Ask about strategies to preserve lean mass, such as resistance training and protein targets, and discuss a plan for tapering or switching therapy to reduce rebound effects